yingweiwo

TGF-β Receptor

TGF-β Receptor

Single pass serine/threonine kinase receptors are TGF-Rs, or transforming growth factor receptors. Transforming growth factor beta (TGF-beta) is a pleiotropic cytokine that participates in a wide range of biological functions, including the regulation of growth, differentiation, migration, cell survival, adhesion, and the specification of developmental fate, in both healthy and pathological conditions. Members of the TGF-beta superfamily communicate via a receptor complex made up of type II and type I receptors, both of which are serine/threonine kinases.At the center of the signaling cascade, the type I receptors, also known as activin receptor-like kinases (ALK), transmit TGF-beta signals to Smad proteins, which are intracellular transcriptional regulators. 
ALKs have extracellular binding domains, transmembrane domains, GS domains that type II receptors use to activate them, and kinase domains that trigger the activation of subsequent signaling molecules. ALKs mediate the effect of TGF-beta superfamily on a variety of cellular processes such as proliferation, differentiation, apoptosis, adhesion and migration, and therefore play important roles in many biological processes. ALKs may make good drug targets because they have been linked to a variety of diseases, including tumorigenesis and immune disorders.

TGF-β Receptor related products

Structure Cat No. Product Name CAS No. Product Description
Itacnosertib (hydrocholide) (TP-0184 (hydrocholide)) V84595 Itacnosertib (hydrocholide) (TP-0184 (hydrocholide)) 2409543-84-4
ITD-1 V22771 ITD-1 1099644-42-4 ITD-1 is a selective inhibitor of TGF-β signaling (IC50 = 0.85 μM); exhibits little or no inhibition of activin, Wnt or BMP signaling pathways.
J-1149 V87102 J-1149 2883580-95-6 J-1149 is a potent ALK5 inhibitor with an IC50 value of 0.017 μM.
KQFK V106344 KQFK 162290-88-2 KQFK is an inactive control for KRFK, a TSP-1-derived peptide that activates TGF-β.
KRFK V67578 KRFK 162290-78-0 KRFK is a bioactive peptide extracted from TSP-1 and can activate TGF-β.
KRFK TFA V76847 KRFK TFA KRFK TFA is a bioactive peptide extracted from TSP-1 and can activate TGF-β.
LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA) (LSKL, Inhibitor of Thrombospondin (TSP-1) trifluoroacetate) V67567 LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA) (LSKL, Inhibitor of Thrombospondin (TSP-1) trifluoroacetate) 2828433-17-4 LSKL, Inhibitor of Thrombospondin (TSP-1) TFA is a tetrapeptide extracted from LAP-TGFβ and is a competitive TGF-β1 antagonist.
LSKL, Inhibitor of Thrombospondin TSP-1 V31090 LSKL, Inhibitor of Thrombospondin TSP-1 283609-79-0 LSKL is a potent and peptide-based inhibitor of Thrombospondin TSP-1 with the potential to be used for treatinghypertrophic scar.
LY3200882 V3756 LY3200882 1898283-02-7 LY3200882 is a next generation,ATP competitive, potent, highly selective small molecule inhibitor of TGF-β receptor type 1 (TGFβRI).
LY550410 V98117 LY550410 737791-20-7 LY550410 is a small molecule ATP-competitive type I TGF-β receptor kinase inhibitor with a heteroaromatic ring that effectively binds to the active site of the kinase domain.
M4K2163 dihydrochloride V84758 M4K2163 dihydrochloride 2863635-04-3
M4K2281 V88161 M4K2281 M4K2281 is a selective inhibitor of activin receptor-like kinase 2 (ALK2) with IC50 of 2 nM.
M4K2306 V88166 M4K2306 3034840-25-7 M4K2306 is a selective inhibitor of activin receptor-like kinase 2 (ALK2) with IC50 of 7 nM.
Maohuoside A V67584 Maohuoside A 128988-55-6 Maohuoside A, a single compound extracted from E.
MU1700 V78829 MU1700 MU1700 is an orally bioactive, potent ALK1/2 inhibitor (antagonist) with IC50s of 13 nM and 6 nM, respectively, which is cell membrane permeable (penetrable) and has high brain permeability.
OXA-06 hydrochloride V84564 OXA-06 hydrochloride 1825455-91-1
Pentabromopseudilin V67586 Pentabromopseudilin 10245-81-5 Pentabromopseudilin (PBrP) is a marine antibiotic extracted from the marine bacteria Pseudomonas bromoutilis and Alteromonas luteoviolaceus.
PKA Substrate V86176 PKA Substrate 121932-31-8
Ramatercept V67585 Ramatercept 1169766-01-1 Ramatercept is a soluble ActRIIB receptor that works as a soluble activin receptor 2 (ACVR2) antagonist.
SB 4 V37829 BMP signaling agonist sb4 100874-08-6 BMP signaling agonist sb4 is a potent benzoxazole bone morphogenetic protein 4 (BMP4) signaling agonist with EC50 of 74 nM and activates BMP signaling by stabilizing intracellular p-SMAD-1/5/9.
Contact Us